Latest News for: gsk
Edit
GSK Velu appointed Chairman of FICCI Tamil Nadu State Council
Business Line 21 Jan 2026
Velu is the Chairman and ...
Edit
GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026
Business Wire 21 Jan 2026
PHILADELPHIA--(BUSINESS WIRE)-- #DiseaseEducation--GSK awards $2M in COiMMUNITY Initiative grants to help close vaccination gaps, commits $3M for 2026 ... .
Edit
GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments
Wall Street Journal 20 Jan 2026
Edit
The Galveston Daily News
20 Jan 2026
Alteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of ...
The Galveston Daily News
20 Jan 2026
Edit
GSK acquiring firm developing food allergy treatment in £1.6bn deal
Belfast Telegraph 20 Jan 2026
Edit
GSK acquiring firm developing food allergy treatment in �1.6bn deal
London Evening Standard 20 Jan 2026
The transaction is expected to complete during the first quarter of 2026 ... .
Edit
GSK to buy US food allergy specialist for $2.2bn
The Times/The Sunday Times 20 Jan 2026
The drugs giant, making its ...
Edit
Hastings Tribune
20 Jan 2026
GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million
Hastings Tribune
20 Jan 2026
Edit
British pharmaceutical company GSK acquires American Rapt Therapeutics for $2.2 billion
AK&M Information Agency 20 Jan 2026
Edit
RAPT Therapeutics stock surges 63% in pre-market trade on Nasdaq after GSK's $2.2 billion acquisition deal
Live Mint 20 Jan 2026
Edit
GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding (GSK plc)
Public Technologies 20 Jan 2026
Edit
GSK to buy RAPT Therapeutics in $2.2 billion deal for promising food allergy therapy
The Economic Times 20 Jan 2026
Edit
GSK to buy food allergy drug maker RAPT in $2.2bn deal
The Guardian 20 Jan 2026
GSK, the UK’s second-biggest drugmaker, has unveiled a $2.2bn (£1.6bn) deal to acquire a Californian biotech company ...
- 1
- 2
- Next page »
